Signals mentioning Mamaearth
- Indian tech start-ups fast-track IPOs; consumer brands Nykaa, Mamaearth, Lenskart lead the charge
- Indian Startups Raise $1.1 Bn This Week; CRED Leads With $900 Mn Series H
- Sofina Ventures Trims Honasa Stake With ₹177 Cr Bulk Deal at ₹424/Share
- Sofina Ventures exits 1.28% of Honasa Consumer in ₹177 Cr bulk deal at ₹424/share
- Sofina Ventures exits 1.28% of Honasa Consumer in ₹177 Cr bulk deal at ₹424/share
- Sofina Ventures exits 1.28% of Honasa Consumer in ₹177 Cr bulk deal at ₹424/share
- Sofina Ventures trims Honasa stake by 1.28% in Rs 177 Cr bulk deal
- Honasa buys 58% of Fluence Pharma for Rs 135 cr, launches Honasa Health to enter VMS market
- Honasa buys 58% of Fluence Pharma, launches Honasa Health to enter nutraceuticals
- Honasa slips 3% after ₹135 cr Fluence Pharma deal to enter nutraceuticals
- Honasa buys 58% of Fluence Pharma at ₹135 cr, pushes Mamaearth parent into nutraceuticals
- Honasa buys 58% of Fluence Pharma for Rs 135 cr, launches Honasa Health for nutraceuticals
- Honasa buys 58% of Fluence Pharma at ₹135 cr EV, enters ₹16,000-cr nutraceuticals via Honasa Health
- Honasa Buys 58% of Fluence Pharma for Rs 135 Cr, Launches Honasa Health for Nutraceuticals
- Honasa Consumer acquires 58% of Fluence Pharma at Rs 135 cr EV, launches Honasa Health subsidiary
- Honasa Buys 58% Of Fluence Pharma, Pushes Mamaearth Into Beauty-From-Within
- Honasa buys 58% of Fluence Pharma for ₹135 Cr, enters nutraceuticals via Honasa Health
- Honasa buys 58% of Fluence Pharma at ₹135 cr EV, enters ₹16,000 cr nutraceuticals market
- Honasa buys 58% of Fluence Pharma at ₹135 cr EV, enters ₹16,000-cr nutraceuticals category
- Honasa Consumer to acquire 58% of Fluence Pharma at Rs 135 cr EV, enters Rs 16,000 cr supplements market